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Obesity-induced insulin resistance is a major
factor in the etiology of type 2 diabetes, and
Jun kinases (JNKs) are key negative regulators
of insulin sensitivity in the obese state. Activa-
tion of JNKs (mainly JNK1) in insulin target cells
results in phosphorylation of insulin receptor
substrates (IRSs) at serine and threonine resi-
dues that inhibit insulin signaling. JNK1 activa-
tion is also required for accumulation of visceral
fat. Here we used reciprocal adoptive transfer
experiments to determine whether JNK1 in my-
eloid cells, such as macrophages, also contrib-
utes to insulin resistance and central adiposity.
Our results show that deletion of Jnk1 in the
nonhematopoietic compartment protects mice
from high-fat diet (HFD)-induced insulin resis-
tance, in part through decreased adiposity.
By contrast, Jnk1 removal from hematopoietic
cells has no effect on adiposity but confers pro-
tection against HFD-induced insulin resistance
by decreasing obesity-induced inflammation.
INTRODUCTION
Type 2 diabetes (T2D) is a common complication of obe-
sity and a sedentary lifestyle (Hu et al., 2001) and a major
threat to human health in the 21st century (Zimmet et al.,
2001). Although the mechanisms by which increased adi-
posity contribute to T2D pathogenesis are still being un-
raveled, it is now well accepted that chronic low-grade
obesity-induced inflammatory responses that lead to acti-
vation of protein kinases, such as IkB kinases (IKKs) and
Jun kinases (JNKs), play an important role in the etiology
of this most common metabolic disease (Hotamisligil,386 Cell Metabolism 6, 386–397, November 2007 ª2007 Elsev2006; Shoelson et al., 2006; White, 2003). JNK family
members are encoded by three genetic loci: the widely
expressed Jnk1 and Jnk2, and Jnk3, which is mainly ex-
pressed in brain and cardiomyocytes (Karin and Gal-
lagher, 2005; Weston and Davis, 2007). JNK1 and JNK2
isozymes have been implicated in obesity-induced glu-
cose intolerance, and JNK1 is believed to be the major
contributor (Hirosumi et al., 2002; Tuncman et al., 2006).
JNK1 is chronically activated in obesity and T2D, at least
in part due to lipotoxic stress (Solinas et al., 2006a;
Weston and Davis, 2007). Interference with JNK1 activity
by either targeted gene disruption or pharmacological
inhibitors protects against obesity-induced insulin resis-
tance (Hirosumi et al., 2002; Kaneto et al., 2004; Tuncman
et al., 2006). Since JNK1 is an attractive target for preven-
tion and treatment of T2D and obesity-induced insulin
resistance (Kaneto, 2005; Karin, 2005; Manning and
Davis, 2003), it is important to fully understand the mech-
anisms by which it participates in the pathogenesis of
glucose intolerance.
Currently, studies on JNK1 action during development
of insulin resistance support a common mechanism
through which JNK1 activation in insulin target cells
directly interferes with insulin signaling (Aguirre et al.,
2000, 2002; Hirosumi et al., 2002; Jaeschke et al., 2004;
Kaneto et al., 2004; Solinas et al., 2006a; White, 2003).
This interference is based on direct phosphorylation of
insulin receptor substrates 1 and 2 (IRS1 and IRS2) at in-
hibitory sites that prevents recruitment to activated insulin
receptors (Aguirre et al., 2000, 2002; Solinas et al., 2006a;
White, 2003). Thus, JNK-mediated IRS phosphorylation
disrupts downstream events such as activation of phos-
phatidylinositol 3-kinase (PI3K) and AKT (Aguirre et al.,
2000, 2002; Lee et al., 2003; Solinas et al., 2006a; White,
2003). Inhibition of JNK1 activation in mouse models of
obesity-induced insulin resistance or in cells treated with
free fatty acids (FFAs) or inflammatory cytokines results
in enhanced insulin-induced PI3K and AKT activationier Inc.
Cell Metabolism
JNK1-Mediated Inflammation and Insulin Resistance(Aguirre et al., 2000, 2002; Hirosumi et al., 2002; Jaeschke
et al., 2004; Kaneto et al., 2004; Lee et al., 2003; Nguyen
et al., 2005; Solinas et al., 2006a).
Studies in Jnk1/ mice have shown that these animals
exhibit a remarkable lean phenotype and are largely pro-
tected from diet-induced obesity (Hirosumi et al., 2002;
Tuncman et al., 2006). In addition to being lean and
more insulin responsive, high-fat diet (HFD)-fed Jnk1/
mice exhibit reduced expression of proinflammatory cyto-
kines such as IL-6, TNF-a, IL-12b, MIF, and MCP1 com-
pared to wild-type (WT) mice (Tuncman et al., 2006).
These data suggest that JNK1 may also be involved in
obesity-induced inflammation. Whether this function and
JNK1 activation in cells other than insulin target cells con-
tribute to the pathogenesis of obesity-induced insulin
resistance and glucose intolerance is not known. We
addressed this question by generating chimeric mice
that lack Jnk1 either in their nonhematopoietic compart-
ment, including all insulin target cells, or only in their hem-
atopoietically derived cells. Our studies show that JNK1
activation in hematopoietically derived cells makes a major
contribution to both HFD-induced inflammation and in-
sulin resistance but has no impact on development of
obesity per se.
RESULTS
Generation of Mice Lacking Jnk1 in Either
Hematopoietic or Nonhematopoietic
Compartments
To determine whether JNK1 in hematopoietically derived
cells contributes to obesity-induced inflammation and glu-
cose intolerance, we used adoptive transfer (Janowska-
Wieczorek et al., 2001; Senftleben et al., 2001) to generate
mice lacking Jnk1 in either radiation-resistant (nonhe-
matopoietic) or hematopoietically derived cells. WT and
Jnk1/ mice were lethally irradiated and reconstituted
with either Jnk1/ or WT bone marrow (Figure 1A). Flow
cytometry showed that 5 weeks after bone marrow trans-
plantation, white blood cells were efficiently reconstituted
and displayed the donor Jnk1 genotype (Figure 1B). Re-
constitution was essentially complete for CD11b+ cells
(99%), the precursors of macrophages and dendritic cells
(Figure 1B). To investigate reconstitution of resident mac-
rophages, we PCR-genotyped different tissues 26 weeks
after reconstitution. We detected chimerism in liver and
adipose tissue, but not in muscle and brain (Figure 1C).
Genotyping of Kupffer cells and parenchymal liver cells
indicated that Kupffer cells were almost fully derived
from the donor bone marrow, whereas the parenchymal
cells were those of the recipient (Figure 1C).
Resistance toDiet-InducedObesity Is Due to JNK1
Deficiency in the Nonhematopoietic Compartment
Previous studies have shown that Jnk1/ mice are resis-
tant to diet-induced obesity (Hirosumi et al., 2002; Tunc-
man et al., 2006). To determine the compartment in which
JNK1 deficiency prevents obesity, WT and Jnk1/ mice,
as well as the bone marrow transplant groups (radiationCell Mchimeras), were fed normal chow or HFD for 20 weeks
starting at week 6 posttransplantation (Figure 1A). As ex-
pected, no differences in body mass were observed in
chow-fed mice (data not shown), and Jnk1/ mice on
HFD were largely protected from diet-induced obesity
(Figure 1D). Importantly, Jnk1/ mice reconstituted with
WT bone marrow (Jnk1/+WT-BM chimeras) also were
protected from HFD-mediated weight gain and obesity.
Magnetic resonance imaging (MRI) after 16 weeks of
HFD showed that Jnk1/ mice were much leaner than
WT mice and that Jnk1/+WT-BM chimeras were leaner
than WT mice reconstituted with Jnk1/ or WT bone
marrow (WT+Jnk1/-BM and WT+WT-BM chimeras)
(Figures 2A and 2B). Quantification of fat pad volumes
by MRI showed that both visceral fat and subcutaneous
fat were reduced in Jnk1/ versus WT mice and in
Jnk1/+WT-BM versus WT+WT-BM and WT+Jnk1/-
BM chimeras (Figures 2A and 2B).
We conclude that resistance to diet-induced obesity in
Jnk1/ mice (Hirosumi et al., 2002) is mainly due to
Jnk1 absence from a radiation-resistant cell type of a non-
hematopoietic origin.
JNK1 Deficiency in the Nonhematopoietic
Compartment Increases Energy Expenditure
and Improves Insulin Sensitivity
Jnk1/ mice have smaller adipocytes than WT mice (Hir-
osumi et al., 2002), suggesting that decreased adiposity
may be due to decreased triglyceride storage rather
than reduced adipocyte number. It has also been reported
that Jnk1/ mice have normal intestinal lipid uptake and
a statistically insignificant tendency toward decreased
food intake and increased body temperature (Hirosumi
et al., 2002). To better understand the cause of the de-
creased adiposity, we performed energy balance studies
by measuring oxygen consumption and food intake for
60 hr. During this period, we found no differences in
food intake between WT and Jnk1/ mice or between
the three groups of radiation chimeras (Figures 2C and
2D). However, oxygen consumption per lean body mass
was significantly higher in Jnk1/ mice compared to their
WTcounterparts (Figure 2C). Furthermore,Jnk1/+WT-BM
chimeras also exhibited a comparable increase in oxygen
consumption relative to WT+WT-BM and WT+Jnk1/-BM
chimeras (Figure 2D). These results indicate that resistance
to obesity in Jnk1/ and Jnk1/+WT-BM mice is due,
at least in part, to increased metabolic rate in a nonhemato-
poietic cell type.
As expected, Jnk1/ mice maintained for 20 weeks on
HFD had improved glucose and insulin tolerance com-
pared to similarly fed WT mice (Figures 3A and 3B).
Jnk1/+WT-BM chimeras on HFD also exhibited im-
proved glucose and insulin tolerance compared to similarly
fed WT+WT-BM chimeras (Figures 3C and 3D). Moreover,
Jnk1/+WT-BM mice displayed lower plasma insulin
levels after intraperitoneal injection of 1 g/kg body weight
of glucose compared to WT+WT-BM chimeras (see Fig-
ure S1 in the Supplemental Data available with this article
online).etabolism 6, 386–397, November 2007 ª2007 Elsevier Inc. 387
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and Nonhematopoietic Jnk1 Knockout
Mice
(A) List of radiation chimeras used in this study
and experimental design.
(B) Quantification of reconstitution at 5 weeks
posttransplantation by flow cytometry of total
white blood cells (WBC), CD11b+ cells, and
CD3+ cells. Jnk1/ cells express the CD45.2
(Ly5.1) marker, whereas wild-type (WT) cells
express the CD45.1 (Ly5.2) marker.
(C) PCR genotyping of tissues obtained from
radiation chimeras 26 weeks after bone mar-
row transplantation. DNA of Jnk1+/ mice
was used as a control (lane 1).
(D) Growth curves of radiation chimeras and
WT and Jnk1/ mice on high-fat diet (HFD).To better understand the basis for the improved glucose
tolerance in Jnk1/ mice and Jnk1/+WT-BM chimeras,
we performed hyperinsulinemic-euglycemic clamp stud-
ies. Although no differences were observed in mice on
chow diet (Figure S2), when maintained on HFD, Jnk1/
mice exhibited higher glucose infusion rates than WT
mice (Figure 4A). The increased insulin sensitivity in
Jnk1/ mice was due to both improved insulin-stimulated
glucose disposal (Figure 4B) and suppression of hepatic
glucose production (Figure 4C). Consistent with the data
in Figure 3, we also observed increased insulin sensitivity
in Jnk1/+WT-BM versus WT+WT-BM chimeras (p <
0.001) (Figure 4A), and this was due to both improved
glucose disposal (p < 0.001) (Figure 4B) and enhanced
suppression of hepatic glucose production (p < 0.001)
(Figure 4C).
To investigate the contribution of reduced obesity to im-
proved insulin sensitivity, we performed glucose clamp388 Cell Metabolism 6, 386–397, November 2007 ª2007 Elseviestudies on a group of WT+WT-BM-L chimeras, chimeric
mice on HFD that were selected post hoc on the basis
of lower body weight than the average for WT+WT-BM
chimeras (33.4 g versus 42.1 g body mass), because of
a more moderate weight gain during HFD feeding and
decreased weight recovery after the clamp surgery. The
glucose infusion rate in the WT+WT-BM-L group was sig-
nificantly higher than in WT+WT-BM chimeras and lower
than in Jnk1/+WT-BM mice, whose average body
mass was 28.3 g (Figures 4A). Likewise, WT+WT-BM-L
chimeras exhibited improved glucose disposal rate and
suppression of hepatic glucose production compared to
WT+WT-BM mice (Figures 4B and 4C), whereas com-
pared to the Jnk1/+WT-BM group, the WT+WT-BM-L
chimeras exhibited decreased suppression of hepatic
glucose production (p < 0.05) and a slightly lower (statisti-
cally insignificant; p = 0.098) glucose disposal rate (Fig-
ures 4B and 4C).r Inc.
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the nonhematopoietic compartment protects against
diet-induced insulin resistance at least in part because it
reduces adiposity.
Absence of Jnk1 from the Hematopoietic
Compartment Improves Insulin Sensitivity
in Mice on High-Fat Diet
As described above, Jnk1 deletion in the hematopoietic
compartment does not affect body weight, adiposity, or
energy expenditure. Nonetheless, WT+Jnk1/-BM chi-
meras showed improved glucose and insulin tolerance
(Figures 3E and 3F) and a faster decrease in serum insulin
following intraperitoneal glucose injection (Figure S1) rela-
tive to the WT+WT-BM group. Consistent with this, hyper-
insulinemic-euglycemic clamp studies demonstrated that,
compared to WT+WT-BM chimeras, WT+Jnk1/-BM
mice show improved glucose infusion rate (Figure 4A)
due to enhanced insulin-stimulated glucose disposal
(Figure 4B) and greater suppression of hepatic glucose
production (Figure 4C).
To test whether deletion of Jnk1 in the hematopoietic
compartment improves insulin signaling, we measured
insulin-induced AKT phosphorylation in livers of WT+
Jnk1/-BM and WT+WT-BM chimeras. The WT+Jnk1/-
BM chimeras maintained on HFD showed higher levels
of insulin-induced AKT activation compared to WT+WT-
BM chimeras maintained on HFD, which were clearly insu-
lin resistant relative to chow-fed counterparts (p < 0.001)
(Figure 4D; Figure S3).
Absence of Jnk1 from the Hematopoietic
Compartment Decreases Obesity-Induced
Inflammation
Jnk1/ mice show decreased liver expression of proin-
flammatory cytokine and chemokine mRNAs (IL-6, TNF-
a, IL-12b, MIF, and MCP1) relative to WT mice (Tuncman
et al., 2006). We assessed whether JNK1 in hematopoietic
cells is directly involved in obesity-induced inflammation.
Both WT+WT-BM and WT+Jnk1/-BM chimeras on HFD
developed hepatosteatosis (Figure S4) and had similar
liver triglyceride content (Figure 5A). However, real-time
PCR analysis revealed decreased expression of IL-6, TNF-
a, IL-12b, MIF, and MCP1, while hepatic expression of
the Kupffer cell marker F4/80 in livers of WT+Jnk1/-BM
chimeras on HFD was comparable to livers of WT+WT-BM
chimeras (Figure 5B; Figure S5A). Similar results, with the
exception of MCP1 mRNA, were observed when adipose
tissue inflammatory mRNAs were measured (Figure 5D).
Adipose tissue from obese rodents and humans is char-
acterized by increased numbers of resident macrophages,
which largely localize around dead adipocytes, forming
crown-like structures (CLSs) (Cinti et al., 2005). To enu-
merate CLSs, we performed MAC2 and 40,6-diamidino-
2-phenylindole (DAPI) staining of adipose tissue sections
from WT+WT-BM and WT+Jnk1/-BM chimeras on HFD.
The results showed that the number of adipose tissue
macrophages in WT+Jnk1/-BM chimeras was less
than half (p < 0.001) of that in WT+WT-BM chimerasCell Me(Figure 5C), despite there being no difference in adipocyte
size (Figure S6) or chemotactic activity of isolated bone
marrow-derived macrophages (Figure S7). Consistent
with these observations, real-time PCR analysis demon-
strated lower mRNA levels of the macrophage marker
F4/80 in adipose tissue from WT+Jnk1/-BM compared
to WT+WT-BM chimeras (Figure 5D). However, there
were no differences in the total number of peripheral blood
Figure 2. Resistance to Diet-Induced Obesity in Jnk1/Mice
Is Mediated by the Nonhematopoietic Compartment
(A) Representative photographs and MRI images of WT mice, Jnk1/
mice, and radiation chimeras after 16 weeks on HFD.
(B) Quantification of total (tot), subcutaneous (su), and visceral (vi) fat
volumes by MRI.
(C) Energy expenditure and food intake of WT and Jnk1/ mice after
16 weeks on HFD. Analysis was performed over three dark (D) and two
light (L) cycles of 12 hr each.
(D) Energy balance study performed as described in (C) using the
indicated radiation chimeras.
**p < 0.001. Error bars represent SD.tabolism 6, 386–397, November 2007 ª2007 Elsevier Inc. 389
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JNK1-Mediated Inflammation and Insulin ResistanceFigure 3. Jnk1 Deletion in the Nonhematopoietic or Hematopoietic Compartments Improves Glucose and Insulin Tolerance in
Response to High-Fat Diet
(A and B) Intraperitoneal glucose tolerance test (GTT) (A) and insulin tolerance test (ITT) (B) of WT and Jnk1/ mice fed either chow or HFD for
20 weeks.
(C and D) GTT (C) and ITT (D) of WT+WT-BM or Jnk1/+WT-BM radiation chimeras fed as above.
(E and F) GTT (E) and ITT (F) of WT+WT-BM or WT+Jnk1/-BM radiation chimeras fed as above.
Error bars represent SEM.monocytes (PBMs) (Figure S8) or the number of myeloid
cells recruited to the peritoneum of WT+Jnk1/-BM and
WT+WT-BM mice injected intraperitoneally with thioglyco-
late (Figure S9). Therefore, the decreased number of CLSs
in WT+Jnk1/-BM mice is not due to a general defect in
macrophage differentiation or recruitment.
To investigate the consequences of reduced adipose
tissue inflammation on production of adipokines and
FFA release, we measured serum levels of leptin, adipo-
nectin, and FFAs. Although no significant differences in
the levels of adipokines between WT+Jnk1/-BM and
WT+WT-BM chimeras were detected, we observed a ten-
dency toward increased adiponectin (p = 0.061) and de-
creased leptin (p = 0.067) in WT+Jnk1/-BM chimeras
compared to the WT+WT-BM group (Figure 5F). Interest-390 Cell Metabolism 6, 386–397, November 2007 ª2007 Elsevingly, WT+Jnk1/-BM mice showed decreased circulat-
ing FFA concentrations, suggesting a role for adipose
tissue macrophages in lipolysis (Figure 5G). Since lipolysis
is inhibited by insulin signaling (Nishino et al., 2007), it
is conceivable that the decreased levels of circulating
FFAs in WT+Jnk1/-BM chimeras are consequent to
improved insulin signaling in adipose tissue due to
decreased inflammation.
JNK1 Is Required for FFA-Mediated Induction
of Proinflammatory Cytokines in Macrophages
We have previously proposed that lipotoxic stress from
long-chain saturated FFAs is a major cause of JNK activa-
tion in obesity (Nguyen et al., 2005; Solinas et al., 2006a). It
has also been reported that long-chain saturated FFAs,ier Inc.
Cell Metabolism
JNK1-Mediated Inflammation and Insulin Resistancebut not polyunsaturated FFAs, induce IL-6 and TNF-a in
macrophages (Shi et al., 2006). Therefore, we tested
whether JNK1 directly regulates expression of proinflam-
matory cytokines in macrophages exposed to long-chain
saturated FFAs. Incubation of peritoneal macrophages
with palmitate (PA) caused robust and sustained JNK
activation, whereas unsaturated FFAs caused a transient
response (Figure 6A; Figure S10). Real-time PCR analysis
Figure 4. Jnk1 Deficiency in the Nonhematopoietic or Hema-
topoietic Compartments Improves Insulin Sensitivity
(A–C) Glucose infusion rate (A), glucose disposal rate (B), and suppres-
sion of hepatic glucose production (HGO) (C) of WT mice, Jnk1/
mice, and radiation chimeras maintained on HFD for 22 weeks. Aver-
age body weight (BW) of the different groups is indicated at top. *p <
0.05; **p < 0.001. Error bars represent SD.
(D) AKT phosphorylation was measured in livers collected after the
clamp from WT+WT-BM and WT+Jnk1/-BM radiation chimeras
fed as above.Cell Meshowed that PA-mediated induction of IL-6 and TNF-
a mRNAs was significantly reduced in peritoneal macro-
phages from Jnk1/ mice (Figure 6B).
Since WT+Jnk1/-BM chimeras maintained on HFD
showed improved hepatic insulin signaling compared to
WT+WT-BM mice (Figures 4C and 4D), we also tested
the role of JNK1 in PA-induced cytokine gene expression
in primary Kupffer cells from WT and Jnk1/ mice. As
seen in peritoneal macrophages, WT Kupffer cells treated
with PA showed sustained JNK activation (Figure 6C) and
induction of IL-6 and TNF-a mRNAs, all of which were
attenuated in Jnk1/ Kupffer cells (Figure 6D).
To test the effect of PA-induced cytokine expression in
macrophages on insulin sensitivity in insulin target cells,
we incubated L6 myotubes with conditioned medium
from WT peritoneal macrophages treated with PA-loaded
BSA, BSA alone, or LPS as a positive control. The results
show that conditioned medium harvested from PA- or
LPS-treated WT macrophages inhibits insulin-dependent
glucose uptake compared to medium from BSA-treated
macrophages (Figure 6E; Figure S11). In contrast, condi-
tioned media from PA- or LPS-treated Jnk1/ macro-
phages did not inhibit insulin-dependent glucose uptake
in L6 myotubes.
Together, these results support the hypothesis that
JNK1 is an important component of the low-grade inflam-
matory response triggered by exposure of myeloid cells
(macrophages, Kupffer cells, dendritic cells, etc.) to satu-
rated FFAs or other molecules associated with obesity.
DISCUSSION
The currently proposed mechanism for JNK action in obe-
sity-induced insulin resistance involves direct inhibitory
phosphorylation of IRS proteins within insulin target tis-
sues such as muscle, liver, and fat (Aguirre et al., 2000,
2002; Hirosumi et al., 2002; Solinas et al., 2006a; White,
2003). JNK-mediated IRS phosphorylation can also inhibit
glucose-induced insulin production by pancreatic b cells
(Solinas et al., 2006a). The studies described above sug-
gest that JNK1 deficiency protects against diet-induced
insulin resistance by at least two additional mechanisms.
Absence of Jnk1 in the nonhematopoietic compartment
prevents diet-induced obesity and leads to indirect im-
provement of insulin sensitivity through maintenance of
leaner body mass. By contrast, Jnk1 deletion in the hema-
topoietic compartment does not affect adiposity or have
a direct effect on insulin receptor signaling but still pro-
tects against HFD-mediated insulin resistance by de-
creasing obesity-induced inflammation. This mechanism
may be particularly amenable to therapeutic intervention.
Jnk1-deficient mice maintained on HFD are leaner than
WT counterparts, with redistribution of adiposity from
subcutaneous to visceral fat, improved insulin sensitivity,
and decreased expression of proinflammatory cytokines
and chemokines (Hirosumi et al., 2002; Tuncman et al.,
2006). We have used reciprocal adoptive transfer experi-
ments to tease apart the different pathophysiological
mechanisms through which JNK1 deficiency contributestabolism 6, 386–397, November 2007 ª2007 Elsevier Inc. 391
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Cells Decreases Obesity-Induced In-
flammation
(A) Liver triglyceride content in WT+WT-BM
and WT+Jnk1/-BM radiation chimeras fed
a HFD for 22 weeks.
(B) Real-time PCR analysis of cytokine and
chemokine mRNA expression in livers of
WT+WT-BM and WT+Jnk1/-BM chimeras
fed either chow or HFD.
(C) MAC2 staining of adipose tissue sections
from the above-described chimeras main-
tained on HFD and quantification of crown-
like structures (CLSs) expressed as a percent-
age of CLS/total nuclei per field.
(D) Real-time PCR analysis of the macrophage
marker F4/80 mRNA in adipose tissue from
radiation chimeras maintained on HFD.
(E) Real-time PCR analysis of cytokine mRNAs
in adipose tissue from radiation chimeras
performed as described in (B).
(F and G) Serum concentrations of adipokines
(F) and free fatty acids (G) in mice maintained
on HFD.
*p < 0.05; **p < 0.01. Error bars represent SD.to these parameters. As previous studies have under-
scored a role for myeloid cells in the development of
insulin resistance by maintaining a chronic, low-grade
obesity-triggered inflammatory response (Arkan et al.,
2005; Lesniewski et al., 2007; Weisberg et al., 2003), we
examined whether JNK1 also acts in the hematopoietic
compartment from which myeloid cells are derived. To
this end, lethally irradiated mice were reconstituted with
bone marrow from different donors and treated with anti-
biotics to reduce postoperative infection and inflammation
(Figure 1A). We also kept these mice on a chow diet for
the first 6 weeks after reconstitution before placing them
on HFD for 20 weeks. Since HFD was given to younger
mice in previous studies (Hirosumi et al., 2002; Tuncman
et al., 2006), we studied ‘‘unmanipulated’’ WT and Jnk1/
mice as a reference. We succeeded in reproducing the
previously reported improved glucose and insulin toler-392 Cell Metabolism 6, 386–397, November 2007 ª2007 Elsevance and obesity resistance of Jnk1/ mice, but not the
subcutaneous/visceral fat redistribution (Hirosumi
et al., 2002), probably due to different experimental condi-
tions. Nonetheless, our results allow dissociation of adi-
pose tissue distribution from obesity-induced inflamma-
tion and insulin sensitivity.
We found that Jnk1/+WT-BM chimeras, but not
WT+Jnk1/-BM chimeras, gained less weight than con-
trols (Figure 1D), demonstrating that mice lacking Jnk1 in
the nonhematopoietic compartment, but not in hematopoi-
etic derivatives, exhibit reduced adiposity (Figures 2A and
2B). Thus, resistance to obesity is due to absence of Jnk1
from a nonhematopoietic cell type whose identity remains
unknownbut could possibly be either the adipocyte itself or
a central nervous system component involved in the con-
trol of energy balance. In this regard, we observed that
mice lacking Jnk1 in the nonhematopoietic compartmentier Inc.
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JNK1-Mediated Inflammation and Insulin ResistanceFigure 6. Induction of TNF-a and IL-6 Gene Expression by Palmitate in Macrophages Is JNK Dependent
(A) Solid-state JNK kinase assays using protein extracts from WT peritoneal macrophages. Cells were treated over a 120 min time course with
different fatty acid-loaded BSA preparations as indicated. (DHA, cis-4,7,10,13,16,19-docosahexaenoic acid.)
(B) Real-time PCR analysis of TNF-a and IL-6 mRNA from WT and Jnk1/ peritoneal macrophages treated with 0.5% BSA or 0.5 mM palmitate (PA)
loaded onto 0.5% BSA for 8 hr.
(C) Solid-state JNK kinase assay using protein extracts from Kupffer cells of WT mice. Cells were treated with 0.5% BSA or 0.5 mM PA loaded onto
0.5% BSA for 120 min.
(D) Real-time PCR analysis of TNF-a and IL-6 mRNA from WT and Jnk1/ Kupffer cells treated as in (B).
(E) Insulin-dependent glucose uptake in L6 myotubes incubated with serum-free conditioned media from peritoneal macrophages treated with 0.5%
BSA, 0.5 mM PA loaded onto 0.5% BSA, or LPS.
*p < 0.05; **p < 0.01. Error bars in (B)–(D) represent SD; error bars in (E) represent SEM.exhibited higher energy expenditure per lean body mass
than control mice despite normal food intake. Since no
difference in body weight was observed in the chow-fed
groups, JNK1 could contribute to obesity by reducing
diet-induced thermogenesis in response to HFD, a condi-
tion that leads to chronic JNK activation (Hirosumi et al.,
2002).
Hyperinsulinemic-euglycemic clamp studies revealed
that improved glucose tolerance in Jnk1/ mice is due
to enhanced liver and peripheral insulin sensitivity. Im-
proved glucose and insulin tolerance were observed in
both Jnk1/+WT-BM and WT+Jnk1/-BM chimeras
(Figure 3), and this was also due to enhanced insulinCell Msensitivity in liver and peripheral organs (Figure 4). Com-
parison of WT+WT-BM chimeras to a leaner group of
control chimeras (WT+WT-BM-L) indicated that improved
insulin responsiveness in Jnk1/+WT-BM mice is par-
tially due to their obesity-resistant phenotype. These re-
sults suggest that pharmacological JNK1 inhibition in non-
hematopoietic tissues could protect against the negative
effects of HFD by increasing metabolic rate, decreasing
adiposity, and improving insulin sensitivity. However,
WT+Jnk1/-BM chimeras showed improved insulin sen-
sitivity without an effect on obesity. Thus, the adoptive
transfer experiment allowed us to dissociate effects on
obesity from effects on insulin resistance in this model,etabolism 6, 386–397, November 2007 ª2007 Elsevier Inc. 393
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ITC, insulin target cells; MC, myeloid cells. The resistance to diet-induced obesity in Jnk1/ mice is due to nonhematopoietic ITCs (mechanism 1).
JNK1 is also directly involved in the development of insulin resistance in ITCs through phosphorylation of IRS1 and IRS2 (mechanism 2) and in MCs by
maintaining metabolic inflammation (mechanism 3).showing that transfer of Jnk1/ hematopoietic cells into
WT animals confers an insulin-sensitive phenotype with
attenuated HFD-induced inflammatory markers. This ob-
servation is fully consistent with a study in which acute
JNK inhibition with a specific peptide inhibitor improved
liver and peripheral insulin sensitivity in obese mice with-
out affecting body weight (Kaneto et al., 2004).
Obesity triggers a chronic low-grade inflammatory
response proposed to promote insulin resistance (Hotami-
sligil, 2006; Shoelson et al., 2006). Obesity-induced in-
flammation involves increased expression of proinflam-
matory cytokines and chemokines and infiltration of
macrophages into adipose tissue, where they surround
dead adipocytes to form typical CLSs (Cinti et al., 2005).
Proinflammatory cytokines in both liver and adipose tis-
sue, as well as the number of CLSs, of HFD-fed mice
were reduced upon Jnk1 deletion in the hematopoietic
compartment. Notably, WT+WT-BM and WT+Jnk1/-
BM animals on HFD show a comparable increase in he-
patic triglycerides and steatosis (Figure 5A; Figure S4),
but nevertheless, the WT+Jnk1/-BM animals do not ex-
hibit hepatic insulin resistance (Figure 4C). Since these
mice manifest Jnk1 deletion in Kupffer cells and not in he-
patocytes, and since their livers show decreased expres-
sion of inflammatory markers (Figure 5B), these results
suggest that increased liver triglycerides and steatosis
are not sufficient to cause severe hepatic insulin resis-
tance in our model and that the inflammatory response
emanating from Kupffer cells is an important cofactor.
Correspondingly, we found that JNK1 contributes to cyto-
kine expression in both peritoneal macrophages and
Kupffer cells exposed to palmitate and that factors se-
creted by JNK1-expressing and palmitate-treated perito-
neal macrophages induce insulin resistance in cultured
myotubes (Figures 6A–6E).
Effects on diet-induced insulin resistance similar to
those observed in WT+Jnk1/-BM chimeras were also
seen in mice with a conditional knockout in myeloid cells
of the proinflammatory kinase IKK and in bone marrow
transplantation chimeras for the Cap gene (Arkan et al.,
2005; Lesniewski et al., 2007). In addition, the effects of
PPAR activation on insulin sensitivity are also in part attrib-
uted to anti-inflammatory action in myeloid cells (Hevener
et al., 2007; Odegaard et al., 2007). At the moment, it is not394 Cell Metabolism 6, 386–397, November 2007 ª2007 Elsevieclear whether JNK1, IKK, Cap, and PPAR control obesity-
induced inflammation via a common pathway, but it is now
evident that interference with genes involved in macro-
phage function can protect against HFD-induced insulin
resistance by decreasing metabolic inflammation.
At present, we do not know the exact mechanism by
which JNK1 inactivation in adipose tissue macrophages
decreases CLS formation. However, the facts that Jnk1/
macrophages display normal chemotactic activity in
response to adipocyte-conditioned medium (Figure S7)
and that WT+Jnk1/-BM chimeras have normal numbers
of PBMs and myeloid cells in the peritoneum after thiogly-
colate injection suggest that the decreased number of
CLSs is not due to a defect in PBM chemotaxis. We
observed that Jnk1/ macrophages display defective in-
duction of proinflammatory cytokines in response to lipo-
toxic stress (Figures 6B and 6D), and WT+Jnk1/-BM
chimeras showed reduced levels of proinflammatory cyto-
kines in adipose tissue (Figure 5E). Our data therefore sug-
gest that expression of proinflammatory cytokines by
adipose tissue macrophages (ATMs) could be required
for efficient ATM recruitment into adipose tissue in re-
sponse to obesity and consequent CLS formation (Fig-
ure S12). Since it has been reported that ATMs are
composed of at least two different populations of macro-
phages expressing different markers and with different
proinflammatory abilities (Lumeng et al., 2007a, 2007b),
it is also plausible that JNK1 could be involved in polariza-
tion of ATMs toward the more inflammatory M1 pheno-
type. Both of these hypotheses imply that CLS formation
is a synergistic process in which macrophage activation
causes more macrophages to be recruited to adipose
tissue, with the end result of increased CLS formation.
Our current understanding of the role of JNK1 in the path-
ogenesis of obesity-induced insulin resistance is depicted
in Figure 7. In summary, JNK activation in a nonhemato-
poietic cell type allows fat accumulation, perhaps through
decreased energy consumption, thereby contributing to in-
sulin resistance via elevated obesity (mechanism 1). As pre-
viously described, obesity-induced chronic JNK activation
interferes with insulin receptor signaling by inhibiting IRS
tyrosine phosphorylation (mechanism 2). In addition, obe-
sity-mediated JNK activation in cells of the hematopoietic
compartment promotes obesity-associated inflammationr Inc.
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sulin resistance in insulin target cells (mechanism 3). This
would represent a two-hit process inwhich JNK1 inmyeloid
cells participates in a process causing paracrine activation
of JNK1 and decreased insulin signaling in insulin target
cells. As myeloid cells could be more accessible to a variety
of peptide and small-molecule JNK inhibitors than other cell
types, our results suggest that targeting JNK within these
cells could make a significant impact in treating insulin
resistance.
EXPERIMENTAL PROCEDURES
Radiation Chimeras
Mice were on the C57BL/6 background. To generate radiation chi-
meras, mice received a lethal dose of 10 Gy of ionizing radiation, fol-
lowed by tail-vein injection of 107 bone marrow cells. To quantify re-
constitution efficiency, we used congenic donors and recipients that
differed at the Ly5.1/Ly5.2 locus. Mice were maintained for 6 weeks
on chow diet, of which 5 weeks included antibiotics (polymyxin
13 mg/l, neomycin 25 mg/l) to allow bone marrow reconstitution with-
out postoperative infection and inflammation. Mice were placed on
HFD 1 week after termination of antibiotic treatment.
Flow Cytometry
Reconstitution efficiency was analyzed by flow cytometric analysis of
congenic Ly5.1 (CD45.2-FITC; BD Pharmingen) and Ly5.2 (Cd45.1-PE;
BD Pharmingen) markers on blood cells costained for CD3e-PE-Cy5
(eBioscience) or CD11b-Tricolor (Caltag) to identify T cells and mono-
cytes/macrophages, respectively. Whole blood was collected and
stained with anti-CD45.2-FITC and anti-CD45.1-PE together with anti-
bodies against T cell or macrophages markers (CD3-CyChrome or
CD11b-Tricolor). Cells were washed twice and red blood cells were
lysed in ACK buffer (eBioscience). After two additional washes, cells
were resuspended in FACS buffer and analyzed via FACSCalibur
(BD Biosciences). Data were plotted using WinMDI2.8 software.
PCR Genotyping
Genomic DNA was extracted from tissues or tails by proteinase K di-
gestion (proteinase K 0.5 mg/ml, 100 mM Tris HCl [pH 8.5], 200 mM
NaCl, 5 mM EDTA, 0.2% SDS) followed by phenol + chloroform extrac-
tion and ethanol precipitation. The following primers were used for
Jnk1 PCR genotyping: forward 50-CACATACACTCAGTGGATCT-30;
reverse WT 50-CACTATGTCCTTAAGACTCC-30; reverse Jnk1 50-TCTT
CGCTATTACGCCAGCT-30.
MRI Analysis and Data Segmentation
After 16 weeks of HFD, lean body mass and fat pad volumes were
measured by MRI. Mice were imaged under 1% isoflurane anesthesia
in a 5 cm custom volume MRI coil using a horizontal bore 7T MR scan-
ner (GE Medical Systems). Images were acquired using a T1-weighted
pulse sequence that rendered fat bright and nonfat tissues dark to
facilitate segmentation. Pulse sequence: 2D spin echo sequence TR/
TE = 8/300, field of view (FOV) 8 cm, phase FOV 50% with a 320 3
160 matrix, slice thickness 500 mm, 10 averages. This provided an
in-plane resolution of 59 mm3. Image data sets were segmented and
volumes were rendered using Amira software (Template Graphic Soft-
ware/Mercury Computer Systems).
Energy Balance
Oxygen consumption and food intake were measured via Comprehen-
sive Lab Animal Monitoring System (Columbus Instruments). Mice
(eight per group) were adapted to metabolic chambers for 2 days be-
fore collecting data every 30 min over three dark and two light cycles
(12 hr each). At the end of the measurement period, metabolic cham-Cell Mebers were inspected for food spillage. Oxygen consumption was
normalized per lean body mass measured by MRI.
Glucose and Insulin Tolerance Tests and Hyperinsulinemic-
Euglycemic Clamps
Glucose and insulin tolerance tests were performed on 6 hr-fasted
mice (Supplemental Experimental Procedures). Blood was collected
at 0, 30, 60, 90, and 120 min after intraperitoneal injection, and glucose
concentration was measured using an Accu-Check Active glucometer
(Roche). For glucose tolerance tests, mice were injected with 1 g/kg
body weight of glucose. For insulin tolerance tests, mice were injected
with 1 IU insulin/kg body weight. Hyperinsulinemic-euglycemic clamps
were performed using 12 mU insulin/kg body weight per minute as pre-
viously described (Hevener et al., 2003) (Supplemental Experimental
Procedures).
Molecular Measurements
Total RNA was extracted from liver, adipose tissue, or macrophage cell
cultures using TRIzol reagent (Invitrogen). cDNA was prepared using
a reverse transcription kit (Promega), and quantitative PCR was per-
formed using a commercial SYBR green mix (PE Applied Biosystems)
and specific primers for MCP1, IL-12b, MIF, TNF-a, and IL-6 as previ-
ously described (Tuncman et al., 2006). Cph was used as housekeep-
ing gene control (Cph forward 50-ATGGTCAACCCCACCGTGT-30;Cph
reverse 50-TTCTTGCTGTCTTTGGAACTTTGTC-30).
For measurement of AKT activation, livers were collected after the
clamp experiments, and phospho-AKT Ser473 was quantified as pre-
viously described (Solinas et al., 2006b). JNK solid-state kinase assays
using GST-cJun(1–79) as a substrate were performed as previously
described (Hibi et al., 1993).
Quantification of Crown-Like Structures
Paraffin-embedded epididymal fat pad sections were stained for
MAC2 (Cedarlane Labs). Stained slides were subsequently coverslip-
ped with DAPI-containing mounting medium (Vector Labs). Bright-field
(MAC2) and fluorescence (DAPI) images were taken of three represen-
tative fields per slide in a blinded fashion using a fluorescence micro-
scope (103 objective). Nuclei per field were quantified by counting
DAPI-positive nuclei using ImageJ software. MAC2-positive CLSs
per field were counted manually, and the percentage of CLSs per total
number of nuclei per field was used as a measure of adipose tissue
macrophage content (Lesniewski et al., 2007).
Primary Macrophage Cell Culture and Insulin-Stimulated
Glucose Uptake in Myotubes
Peritoneal macrophages were isolated from WT or Jnk1/ mice by
peritoneal lavage 4 days after injection of 3 ml of 3% thioglycolate
(Difco, BD Diagnostics) and plated in six-well plates at 106 cells/well.
Kupffer cells were prepared by two-step liver collagenase digestion
and fractionation on a Percoll gradient as previously described (Nnalue
et al., 1992). The detailed protocol for glucose uptake in L6 myotubes
is provided in Supplemental Experimental Procedures.
Statistical Analyses
Differences between two sets of data were compared by Student’s
t test, and differences over time (GTTs and ITTs) were compared by
two-way ANOVA. Differences were considered significant at p < 0.05.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures
and 12 figures and can be found with this article online at http://
www.cellmetabolism.org/cgi/content/full/6/5/386/DC1/.
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